More Company News

Redx Pharma

Presentation of preclinical RXC009 data
06 Nov 2023Read More

Redx Pharma

Preclinical RXC009 data to be presented at ASN
30 Oct 2023Read More

Redx Pharma

Proposed subscription to raise c.£14.1m
18 Oct 2023Read More

Redx Pharma

Zelasudil (RXC007) granted FDA Orphan Drug Designation
21 Aug 2023Read More

Redx Pharma

Extension to CLN
10 Jul 2023Read More

Redx Pharma

Interim H123 results for the six months ended 31 March
17 May 2023Read More

Redx Pharma

RXC007 preclinical data
11 May 2023Read More

Redx Pharma

Presentation at Keystone Symposia
03 May 2023Read More

Redx Pharma

Proposed business combination formally lapsed
03 Apr 2023Read More

Redx Pharma

Statement following Jounce announcement
27 Mar 2023Read More

1 2 3 4 … 7
Return to Redx Pharma
© 2019-22 Trinity Delta. All rights reserved. Trinity Delta is regulated by the Financial Conduct Authority (Reference number: 725161).